Skip to main content

Animations

MJFF Publications

6801 - 6810 of 8801 Results
Title
Year
  • Year
  • 2020
  • 2025
  • 2022
  • 2020
  • 2014
  • 2021
  • 2023
  • 2022
  • 2020
  • 2022
  • Summary Details
    OPEN
    Title: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.00370
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Exploring the neuroprotective potential of immunosuppressants in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Heterogeneous pain trajectories in persons with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.07.006
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.01.010
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-020-05149-3
    Citation Count: 46
  • Summary Details
    RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51482
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 24
  • Summary Details
    RESTRICTED
    Title: Parkinson's Progression Markers Initiative brain autopsy program
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.017
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.